Exercise mitigates cardiac doxorubicin accumulation and preserves function in the rat

J Cardiovasc Pharmacol. 2013 Sep;62(3):263-9. doi: 10.1097/FJC.0b013e3182982ce0.

Abstract

Purpose: Doxorubicin (DOX) is an effective antineoplastic agent with well-characterized cardiotoxic effects. Although exercise has been shown to protect against DOX cardiotoxicity, a clear and concise mechanism to explain its cardioprotective effects is lacking. The purpose of this study was to determine if exercise training reduces cardiac DOX accumulation, thereby providing a possible mechanism to explain the cardioprotective effects of exercise against DOX toxicity.

Methods: Sprague-Dawley rats were randomly assigned to 1 of 3 primary experimental groups: sedentary (n = 77), wheel running (n = 65), or treadmill (n = 65). Animals in wheel running and treadmill groups completed 10 weeks of exercise before DOX treatment. DOX was administered 24 hours after the last training session as a bolus intraperitoneal injection at 10 mg/kg. Subgroups of rats from each primary group were killed at 1, 3, 5, 7, and 9 days after DOX exposure to assess cardiac function and DOX accumulation.

Results: Ten weeks of exercise preconditioning reduced myocardial DOX accumulation, and this reduction in accumulation was associated with preserved cardiac function.

Conclusions: These data suggest that the cardioprotective effects of exercise against DOX-induced injury may be due, in part, to a reduction in myocardial DOX accumulation.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / administration & dosage
  • Antibiotics, Antineoplastic / adverse effects
  • Antibiotics, Antineoplastic / analysis
  • Antibiotics, Antineoplastic / pharmacokinetics*
  • Behavior, Animal
  • Cardiotoxins / administration & dosage
  • Cardiotoxins / adverse effects
  • Cardiotoxins / analysis
  • Cardiotoxins / pharmacokinetics*
  • Coronary Circulation / drug effects
  • Coronary Disease / chemically induced
  • Coronary Disease / diagnostic imaging
  • Coronary Disease / physiopathology
  • Coronary Disease / prevention & control*
  • Doxorubicin / administration & dosage
  • Doxorubicin / adverse effects
  • Doxorubicin / analysis
  • Doxorubicin / pharmacokinetics*
  • Echocardiography
  • Female
  • Heart / drug effects*
  • Heart / physiopathology
  • Injections, Intraperitoneal
  • Motor Activity*
  • Myocardium / chemistry*
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Tissue Distribution

Substances

  • Antibiotics, Antineoplastic
  • Cardiotoxins
  • Doxorubicin